The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: IG Design plunges after profit warning

Wed, 26th Jan 2022 11:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Sensyne Health PLC, up 25% at 19.00 pence, 12-month range 14.00p-190.00p. The healthcare technology firm says it has successfully completed a financing agreement for up to GBP11.4 million. Earlier this month, Sensyne had warned it would not be able to trade beyond February without the cash injection.

----------

Revolution Beauty Group PLC, up 14% at 110.00p, 12-month range 95.18p-173.00p. The beauty and personal care products maker and retailer reports strong sales over the peak Christmas trading period, which increased 41% year-on-year on an underlying basis. Says this was achieved despite a volatile consumer backdrop with many markets going into lockdown. Expands into US with product rollout into over 2,800 Walgreens stores.

----------

Deltex Medical Group PLC, up 5.1% at 1.26p, 12-month range 1.05p-2.34p. The medical devices manufacturer wins contract worth USD200,000 for its TrueVue monitors from an unnamed "key distributor" in the Americas.

----------

AIM - LOSERS

----------

IG Design Group PLC, down 55% at 114.00p, 12-month range 113.00p-625.00p. Shares in craft, gifting and stationery maker hit 12-month low as it says supply chain problems, rising raw material and fulfilment costs, and a drop in demand for crafting in the US have hurt trading. IG Design now expects its financial 2022 adjusted operating profit to fall to a breakeven position, resulting in full year earnings significantly below current market expectations. Says there will be no final dividend payment in relation to the current year and expects that external challenges will continue into financial 2023.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 Jan 2022 09:50

Sensyne shares drop as it seeks shareholder funds to continue trading

Sensyne shares drop as it seeks shareholder funds to continue trading

Read more
24 Dec 2021 08:47

Sensyne wins two agreements for its Sensight AI data platform

Sensyne wins two agreements for its Sensight AI data platform

Read more
24 Dec 2021 08:25

Sensyne strikes one-year agreement with Exscientia

(Sharecast News) - Clinical artificial intelligence company Sensyne Health has struck a one-year agreement with Exscientia to leverage "the deep learning AI capabilities" of its platform to study real-world health data.

Read more
3 Dec 2021 17:29

Sensyne Health enters research agreement with NHS Foundation trust

Sensyne Health enters research agreement with NHS Foundation trust

Read more
3 Dec 2021 14:42

Sensyne signs five-year patient data deal with Cambridge NHS trust

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year, non-exclusive strategic research agreement with Cambridge University Hospitals NHS Foundation Trust, it announced on Friday.

Read more
30 Nov 2021 19:13

TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim

TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim

Read more
2 Nov 2021 17:11

IN BRIEF: Sensyne Health considers management buyout of company

IN BRIEF: Sensyne Health considers management buyout of company

Read more
22 Oct 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
21 Oct 2021 17:55

IN BRIEF: Sensyne partner Excalibur gets European Covid test approval

IN BRIEF: Sensyne partner Excalibur gets European Covid test approval

Read more
15 Oct 2021 18:12

TRADING UPDATES: Miton Global to become MIGO; Guild makes new signings

TRADING UPDATES: Miton Global to become MIGO; Guild makes new signings

Read more
15 Oct 2021 14:44

Sensyne enters health data partnership with US-based OMNY

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced a new strategic relationship with US-based data network company OMNY Health on Friday.

Read more
1 Oct 2021 11:15

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

Read more
24 Sep 2021 16:03

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Sep 2021 18:16

TRADING UPDATES: Cohort gets contract extension; IQGeo wins new deal

TRADING UPDATES: Cohort gets contract extension; IQGeo wins new deal

Read more
2 Sep 2021 21:44

TRADING UPDATES: Challenger Energy hails Saffron-2 well; SDCL placing

TRADING UPDATES: Challenger Energy hails Saffron-2 well; SDCL placing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.